FOLLOW US 
Biotechnology
The KAWG supports the development of transgenic wheat technologies
through private and public research. These research investments should
provide profitability benefits to the producer-customers as well as
reasonable returns to the technology providers. (August, 2007)
The KAWG supports the initiatives as spelled out in the Principles for Commercialization document developed by the Joint Biotech Committee. (November, 2006)
The KAWG supports the following National Joint Biotechnology Committee position statement: Biotechnological research holds great promise for the future, and the U.S. wheat industry recognizes these advancements. In preparation for the future commercialization of biotechnologically-derived wheat, we take the following positions:
1. We support and will work to ensure the ability of wheat producers to make planting and marketing choices based on economic, agronomic, and market factors.
2. We support the ability of our wheat customers to make purchases on the basis of specific traits. We commit ourselves to the principle that our customers needs are vitally important.
3. We support and will assist in the development by all segments of the industry of an orderly marketing system to assure delivery of non-transgenic wheat within reasonable tolerances to markets that require it.
4. We urge the adoption of a nationally and internationally accepted definition of biotechnologically-derived products. * We also urge international harmonization of scientific standards and trade rules.
5. We support voluntary labeling of food products, provided it is consistent with U.S. law and international trade agreements and is truthful and not midleading. We oppose government- mandated labeling of wheat products in both the U.S. and international markets based on the presence or absence of biotechnologically derived traits that do not differ significantly from their conventional counterpart.
6. We support the establishment of a reasonable threshold level for adventitious or accidental inclusion of biotechnlogically derived traits in bulk wheat or wheat food products in both U.S. and international markets.
7. We are confident that biotechnology will deliver significant consumer and producer benefits. We support continued biotechnology research, andproduct and market development. We invite valued and interested customers to join with us in a working partnership to explore the emerging biotechnology industry.
Notes to the above:
*U.S. Wheat Industry definition: Biotechnologically-derived (Genetically Modified Organisms) genetically modified organisms (commonly referred to as "transgenic") are organisms derived from somatic cell fusion or direct insertion of a gene construct, typically but not necessarily from a sexually-incompatible species, using recombinant DNA technoques and any genetic transformation technology (e.g., bacterial vectors, particle bombardment, electroporation).
[1., 2., 3., 6.,] Adopted by U.S. Wheat Board of Directors and the National Association of Wheat Growers board of directors on February 2006 (November, 2006)
The KAWG supports the initiatives as spelled out in the Principles for Commercialization document developed by the Joint Biotech Committee. (November, 2006)
The KAWG supports the following National Joint Biotechnology Committee position statement: Biotechnological research holds great promise for the future, and the U.S. wheat industry recognizes these advancements. In preparation for the future commercialization of biotechnologically-derived wheat, we take the following positions:
1. We support and will work to ensure the ability of wheat producers to make planting and marketing choices based on economic, agronomic, and market factors.
2. We support the ability of our wheat customers to make purchases on the basis of specific traits. We commit ourselves to the principle that our customers needs are vitally important.
3. We support and will assist in the development by all segments of the industry of an orderly marketing system to assure delivery of non-transgenic wheat within reasonable tolerances to markets that require it.
4. We urge the adoption of a nationally and internationally accepted definition of biotechnologically-derived products. * We also urge international harmonization of scientific standards and trade rules.
5. We support voluntary labeling of food products, provided it is consistent with U.S. law and international trade agreements and is truthful and not midleading. We oppose government- mandated labeling of wheat products in both the U.S. and international markets based on the presence or absence of biotechnologically derived traits that do not differ significantly from their conventional counterpart.
6. We support the establishment of a reasonable threshold level for adventitious or accidental inclusion of biotechnlogically derived traits in bulk wheat or wheat food products in both U.S. and international markets.
7. We are confident that biotechnology will deliver significant consumer and producer benefits. We support continued biotechnology research, andproduct and market development. We invite valued and interested customers to join with us in a working partnership to explore the emerging biotechnology industry.
Notes to the above:
*U.S. Wheat Industry definition: Biotechnologically-derived (Genetically Modified Organisms) genetically modified organisms (commonly referred to as "transgenic") are organisms derived from somatic cell fusion or direct insertion of a gene construct, typically but not necessarily from a sexually-incompatible species, using recombinant DNA technoques and any genetic transformation technology (e.g., bacterial vectors, particle bombardment, electroporation).
[1., 2., 3., 6.,] Adopted by U.S. Wheat Board of Directors and the National Association of Wheat Growers board of directors on February 2006 (November, 2006)
